September 2022
Lived Experiences of Dyads with a Left Ventricular Assist Device: Lessons Learned for Around the World
Dr. Angela Massouh
Beirut, Lebanon
Dr. Loreena Hill
Belfast, Ireland
In September’s HFA Cardio Talk, Dr. Angela Massouh interviews Dr. Loreena Hill on living with a left ventricular assist device, and lessons learned from around the globe. This podcast addresses the experiences of patients living with a left ventricular assist device and their informal caregivers. It will also highlight clinical aspects of self-care and how international multidisciplinary healthcare providers can do better to assist this vulnerable group.
July 2022
Gene Editing: Paving the way to end the burden of inherited cardiomyopathies or just a useful research tool?
Dr. Emma Louise Robinson
Aurora, Colorado, U.S
Prof. Luisa Mestroni
Aurora, Colorado, U.S
In July’s HFA Cardio Talk podcast, Dr Emma Robinson interviews Prof Luisa Mestroni, Director of the International Familial Cardiomyopathy Registry and Co-Director of the Molecular Genetics Program of the Cardiovascular Institute in Denver. This podcast discusses current approaches to diagnosis, treatment options and support for patients and families of inherited cardiomyopathy as well as how advances in gene editing have transformed translational research, understanding of disease mechanisms and prospects for clinical care.
June 2022
HFpEF – The enigma of Heart Failure
Assist. Prof. Markus Wallner
Graz, Austria
Prof. Rudolf de Boer
Groningen, the Netherlands
This podcast will discuss the most recent developments in heart failure with preserved ejection fraction (HFpEF). Prof. de Boer, HFA board member and HFpEF expert, is interviewed by Dr. Wallner, chair of the HoT Committee, and will walk us through the diagnostic and therapeutic challenges of HFpEF and provide tips and tricks for the management of patients with HFpEF.
May 2022
Insights and prospects from the Heart Failure Congress 2022, Madrid, Spain
Dr. Antonio Cannata
London, UK
Dr. Mateusz Sokolski,
Wrocław, Poland
Dr. Otilia Țica
Oradea, Romania
Prof. Finn Gustafsson
Copenhagen, Denmark
Prof. John Cleland
London, UK
Prof Theresa McDonagh
London, UK
Prof. Gianluigi Savarese
Stockholm, Sweden
Prof Carolyn Lam
Singapore
Prof. Marco Metra
Brescia, Italy
This podcast will discuss the insights and highlights shared by key-leaders in heart failure during the annual meeting: Heart Failure Congress, held in Madrid, Spain. Prof. Gustafson offers an overview on advanced heart failure therapies and the role of MCS (mechanical circulatory support). Prof Cleland debates when should we attempt revascularisation in heart failure patients. Prof McDonagh shares the updates and changes in the implementation of the HF guidelines in the last year, since their release. Prof Savarese highlights the best scientific statement of this year, the universal definition of Heart Failure. Prof Lam provides key message and trials in HF and also underlines the sex-differences in these patients. Prof Metra discusses the pillars and future perspectives of HF and the importance of education.
April 2022
Tips and tricks in interpretation of clinical trials
Prof. Petar M. Seferović
Belgrade, Serbia
Dr. Ivan Milinković
Belgrade, Serbia
The podcast discusses how major clinical trials changed the perspective on how randomized clinical trials are designed, conducted and interpreted. It gives the insight into major positive and negative aspects of the clinical trials, which results influenced the contemporary heart failure treatment
March 2022
Implementing the use of HF treatments in clinical practice
Prof. Gianluigi Savaresse
Stockholm, Sweden
Dr. Otilia Țica
Oradea, Romania
This podcast will discuss the optimal implementation of heart failure therapies: guidelines, and challenges. It tackled how registries support implementation of care and trial design in heart failure. Prof. Gianluigi Savaresse interviewed by Dr Otilia Țica, member of HOT committee, will guide us throughout the challenges of implementing optimal therapies in HF and will offer an insight on how registries can help directly improve quality of care.
February 2022
The SGLT2-inhibitors revolution in Heart Failure. Current indications and future perspectives
Giuseppe Rosano
London, UK
Dr. Antonio Cannata
London, UK
This podcast will discuss the most recent and serendipitous revolution in the field of Heart Failure, the SGLT2-inhibitors, their indications and future perspectives. Prof Rosano, interviewed by Dr Cannata, will drive through the most recent evidence supporting the use of SGLT2-i in patients with heart failure. Let's see whether an apple a day truly keeps the doctor away.
January 2022
Medical treatment for heart failure. News and controversies from 2021 ESC heart failure Guidelines
Prof. Ewa A. Jankowska
Wroclaw, Poland
Mateusz Sokolski
Wroclaw, Poland
The podcast presents the news and controversies related to 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The discussion between co-author of the guidelines and member of HOT Committee covers the important clinical aspects of medical treatment of heart failure and co-morbidities taking into account some doubts coming from guidelines and gaps in evidence.
Our mission: To reduce the burden of cardiovascular disease.